These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 29677618)

  • 21. Serum levels of BDNF, folate and homocysteine: in relation to hippocampal volume and psychopathology in drug naïve, first episode schizophrenia.
    Song X; Fan X; Li X; Kennedy D; Pang L; Quan M; Chen X; Gao J; Zhang W; Zhang J; Lv L
    Schizophr Res; 2014 Oct; 159(1):51-5. PubMed ID: 25128453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Involvement of vascular endothelial growth factor in schizophrenia.
    Rampino A; Annese T; Torretta S; Tamma R; Falcone RM; Ribatti D
    Neurosci Lett; 2021 Aug; 760():136093. PubMed ID: 34216717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated serum vascular endothelial growth factor in treatment-resistant schizophrenia treated with electroconvulsive therapy: Positive association with therapeutic effects.
    Xiao W; Zhan Q; Ye F; Tang X; Li J; Dong H; Sha W; Zhang X
    World J Biol Psychiatry; 2019 Feb; 20(2):150-158. PubMed ID: 29611450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased interleukin-10 serum levels in first-episode drug-naïve schizophrenia: relationship to psychopathology.
    Xiu MH; Yang GG; Tan YL; Chen DC; Tan SP; Wang ZR; Yang FD; Okusaga O; Soares JC; Zhang XY
    Schizophr Res; 2014 Jun; 156(1):9-14. PubMed ID: 24766914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased interleukin-2 serum levels were associated with psychopathological symptoms and cognitive deficits in treatment-resistant schizophrenia.
    Tan Y; Li Y; Tan S; Wang Z; Yang FD; Cao B; Zunta-Soares GB; Soares JC; Zhang XY
    Schizophr Res; 2015 Dec; 169(1-3):16-21. PubMed ID: 26549630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced serum TNF alpha level in chronic schizophrenia patients with or without tardive dyskinesia.
    Tian L; Tan Y; Chen D; Lv M; Tan S; Soares JC; Zhang XY
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():259-64. PubMed ID: 24995685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gender differences in never-medicated first-episode schizophrenia and medicated chronic schizophrenia patients.
    Zhang XY; Chen DC; Xiu MH; Yang FD; Haile CN; Kosten TA; Kosten TR
    J Clin Psychiatry; 2012 Jul; 73(7):1025-33. PubMed ID: 22901352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vascular endothelial growth factor in major depressive disorder, schizophrenia, and bipolar disorder: A network meta-analysis.
    Pu J; Liu Y; Gui S; Tian L; Xu S; Song X; Zhong X; Chen Y; Chen X; Yu Y; Liu L; Zhang H; Wang H; Zhou C; Zhao L; Xie P
    Psychiatry Res; 2020 Oct; 292():113319. PubMed ID: 32717712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurocognition and social cognition in remitted first-episode schizophrenia: correlation with VEGF serum levels.
    Zhao Y; Xiao W; Chen K; Zhan Q; Ye F; Tang X; Zhang X
    BMC Psychiatry; 2019 Dec; 19(1):403. PubMed ID: 31842818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated plasma superoxide dismutase in first-episode and drug naive patients with schizophrenia: inverse association with positive symptoms.
    Wu Z; Zhang XY; Wang H; Tang W; Xia Y; Zhang F; Liu J; Fu Y; Hu J; Chen Y; Liu L; Chen DC; Xiu MH; Kosten TR; He J
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Jan; 36(1):34-8. PubMed ID: 21896300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nerve growth factor and brain-derived neurotrophic factor concentrations in schizophrenia: a review.
    Martinotti G; Di Iorio G; Marini S; Ricci V; De Berardis D; Di Giannantonio M
    J Biol Regul Homeost Agents; 2012; 26(3):347-56. PubMed ID: 23034254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytokine serum levels, autologous mixed lymphocyte reaction and surface marker analysis in never medicated and chronically medicated schizophrenic patients.
    Theodoropoulou S; Spanakos G; Baxevanis CN; Economou M; Gritzapis AD; Papamichail MP; Stefanis CN
    Schizophr Res; 2001 Jan; 47(1):13-25. PubMed ID: 11163541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increase systemic levels of IL-23 as a possible constitutive marker in schizophrenia.
    Borovcanin M; Jovanovic I; Dejanovic SD; Radosavljevic G; Arsenijevic N; Lukic ML
    Psychoneuroendocrinology; 2015 Jun; 56():143-7. PubMed ID: 25827958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment.
    Pirildar S; Gönül AS; Taneli F; Akdeniz F
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jul; 28(4):709-13. PubMed ID: 15276697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsychotics.
    Khan MM; Evans DR; Gunna V; Scheffer RE; Parikh VV; Mahadik SP
    Schizophr Res; 2002 Nov; 58(1):1-10. PubMed ID: 12363384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased serum prolactin levels in drug-naive first-episode male patients with schizophrenia.
    Albayrak Y; Beyazyüz M; Beyazyüz E; Kuloğlu M
    Nord J Psychiatry; 2014 Jul; 68(5):341-6. PubMed ID: 24094029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxidative stress in drug naïve first episode psychosis and antioxidant effects of risperidone.
    Noto C; Ota VK; Gadelha A; Noto MN; Barbosa DS; Bonifácio KL; Nunes SO; Cordeiro Q; Belangero SI; Bressan RA; Maes M; Brietzke E
    J Psychiatr Res; 2015 Sep; 68():210-6. PubMed ID: 26228421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased levels of serum basic fibroblast growth factor in schizophrenia.
    Hashimoto K; Shimizu E; Komatsu N; Nakazato M; Okamura N; Watanabe H; Kumakiri C; Shinoda N; Okada S; Takei N; Iyo M
    Psychiatry Res; 2003 Oct; 120(3):211-8. PubMed ID: 14561432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ndel1 oligopeptidase activity as a potential biomarker of early stages of schizophrenia.
    Dal Mas C; Nani JV; Noto C; Yonamine CM; da Cunha GR; Mansur RB; Ota VK; Belangero SI; Cordeiro Q; Kapczinski F; Brietzke E; Bressan RA; Gadelha A; Hayashi MAF
    Schizophr Res; 2019 Jun; 208():202-208. PubMed ID: 30857875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brain-derived neurotrophic factor blood levels are decreased in schizophrenia patients and associate with rs6265 genotypes.
    Zakharyan R; Boyajyan A
    Clin Biochem; 2014 Aug; 47(12):1052-5. PubMed ID: 24713399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.